Related Experiment Video
Updated: Jul 14, 2025

Th17 Inflammation Model of Oropharyngeal Candidiasis in Immunodeficient Mice
Published on: February 18, 2015
Thymoquinone attenuates inflammation in C. Albicans keratitis by activating Nrf2/HO-1 signaling pathway and reducing
Hua Yao1, Liting Hu1, Nan Jiang1
1Department of Ophthalmology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong Province, China.
Purpose:
This study aims to investigate the anti-inflammatory and antifungal properties of thymoquinone (TQ) and elucidate its mechanism of action in the context of C. albicans keratitis.
Methods:
Various methods were employed to identify a safe and effective concentration of TQ with antifungal properties, including the determination of the minimum inhibitory concentration (MIC), the cell counting kit-8 (CCK-8) test, and the Draize experiment. The severity of fungal keratitis (FK) was assessed through clinical ratings and slit-lamp imaging. Fungus burden was determined using plate counting and periodic acid Schiff (PAS) staining. Neutrophil infiltration and activity were investigated through immunofluorescence staining (IFS), myeloperoxidase (MPO) analysis, and hematoxylin and eosin (HE) staining. To explore the anti-inflammatory effects of TQ and its mechanism of action, we employed RT-PCR, ELISA, and western blot techniques.
Results:
TQ effectively controlled fungal growth at a concentration of 50 µg/mL while preserving the integrity of mouse corneas. Human corneal epithelial cells (HCECs) remained unaffected by TQ at concentrations ≤ 3.75 µg/mL. Treatment with TQ led to significant improvements in clinical scores, fungal burden, neutrophil infiltration, and the expression of inflammatory factors compared to the DMSO group. Moreover, TQ demonstrated the ability to reduce the levels of inflammatory factors in HCECs stimulated by C. albicans. Additionally, TQ enhanced the expressions of Nrf2 and HO-1 in mouse corneas. The downregulation of cytokines induced by TQ was reversed upon pretreatment with inhibitors of Nrf2 or HO-1.
Conclusion:
TQ exhibits a protective effect in the context of C. albicans keratitis through multiple mechanisms, including inhibition of C. albicans growth, reduction of neutrophil recruitment, activation of the Nrf2/HO-1 pathway, and limitation of the expression of pro-inflammatory factors.
Insights
Thymoquinone (TQ) effectively treats fungal keratitis by inhibiting Candida albicans growth and reducing inflammation. It activates the Nrf2/HO-1 pathway, offering a protective effect against this eye infection.
Area of Science:
- Ophthalmology
- Mycology
- Pharmacology
Background:
- Fungal keratitis (FK) caused by Candida albicans is a significant cause of vision loss.
- Current treatments for FK can have limitations and side effects.
- Thymoquinone (TQ), a compound from black seed oil, shows potential therapeutic properties.
Purpose of the Study:
- To investigate the anti-inflammatory and antifungal effects of thymoquinone (TQ) on Candida albicans keratitis.
- To elucidate the mechanism of action of TQ in treating fungal keratitis.
- To determine safe and effective concentrations of TQ for corneal application.
Main Methods:
- Minimum inhibitory concentration (MIC) and cell viability assays (CCK-8) were used to determine TQ efficacy and safety.
- Clinical FK severity, fungal burden, and neutrophil infiltration were assessed in vivo.
- Gene and protein expression of inflammatory factors, Nrf2, and HO-1 were analyzed using RT-PCR, ELISA, and Western blot.
Main Results:
- TQ demonstrated antifungal activity against C. albicans at 50 µg/mL with corneal safety up to 3.75 µg/mL.
- TQ treatment significantly improved clinical scores, reduced fungal burden, and decreased neutrophil infiltration.
- TQ inhibited inflammatory factors and activated the Nrf2/HO-1 pathway, with effects reversed by pathway inhibitors.
Conclusions:
- Thymoquinone exerts protective effects against C. albicans keratitis.
- TQ acts via multiple mechanisms: inhibiting fungal growth, reducing inflammation, and activating the Nrf2/HO-1 pathway.
- TQ shows promise as a therapeutic agent for fungal keratitis.
Related Concept Videos
Gene Regulation in Microbial Communities: Quorum Sensing
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Fungal Phylum Microsporidia

